Innovative Med Concepts, LLC
Records under this name other than patents Innovative Med Concepts, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Innovative Med Concepts, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,809,351 | Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,040,546 | Method of treating functional somatic syndromes with combination of famciclovir and celecoxib Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,173,863 | Antiviral compound and COX-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,259,405 | Method of treating functional somatic syndromes with combination of famciclovir and diclofenac Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,682,051 | Acyclovir and meloxicam combination therapy for functional somatic syndromes Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,034,846 | Famciclovir and celecoxib combination therapy for functional somatic syndromes Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,251,853 | Synergistic famciclovir and celecoxib combination therapy for functional somatic syndromes Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,642,824 | Valaciclovir and diclofenac combination therapy for functional somatic syndromes Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,096,912 | Valaciclovir and celecoxib combination for functional somatic syndromes Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,632,087 | Famciclovir and meloxicam combination therapy for functional somatic syndromes Formerly held In force · From the USPTO record | In force | From the USPTO record |